An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Magenta Therapeutics to Participate in 2021 Cantor Virtual Global Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Magenta Therapeutics, Inc. (NASDAQ: MGTA), a clinical-stage biotechnology company, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, at 4:40 p.m. ET. The event aims to showcase the company's innovative approaches in stem cell transplant therapies for patients with blood cancers and genetic diseases. A live webcast will be available on the Magenta website, with a replay accessible for 90 days post-event. For further details, please visit www.magentatx.com.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Magenta Therapeutics, Inc. (Nasdaq:MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28 at 4:40 p.m. ET.
About Magenta Therapeutics Magenta Therapeutics is a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.
When will Magenta Therapeutics participate in the Cantor Virtual Global Healthcare Conference?
Magenta Therapeutics will participate in the conference on Tuesday, September 28, 2021, at 4:40 p.m. ET.
How can I watch the Magenta Therapeutics fireside chat?
The fireside chat can be accessed via a live webcast on the Magenta Therapeutics website.
What is the focus of Magenta Therapeutics' business?
Magenta Therapeutics focuses on developing novel medicines to bring stem cell transplant curative power to patients with blood cancers and genetic diseases.
Where is Magenta Therapeutics headquartered?
Magenta Therapeutics is headquartered in Cambridge, Massachusetts.
How long will the webcast replay of the fireside chat be available?
The webcast replay will be available for 90 days following the event.
